298 related articles for article (PubMed ID: 25880423)
1. Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.
Arismendi M; Giraud M; Ruzehaji N; Dieudé P; Koumakis E; Ruiz B; Airo P; Cusi D; Matucci-Cerinic M; Salvi E; Cuomo G; Hachulla E; Diot E; Caramaschi P; Riccieri V; Avouac J; Kayser C; Allanore Y
Arthritis Res Ther; 2015 Mar; 17(1):71. PubMed ID: 25880423
[TBL] [Abstract][Full Text] [Related]
2. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
[TBL] [Abstract][Full Text] [Related]
3. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
[TBL] [Abstract][Full Text] [Related]
4. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
[TBL] [Abstract][Full Text] [Related]
5. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
[TBL] [Abstract][Full Text] [Related]
6. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis.
Xu Y; Wang W; Tian Y; Liu J; Yang R
Int J Dermatol; 2016 Apr; 55(4):408-16. PubMed ID: 26712637
[TBL] [Abstract][Full Text] [Related]
8. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
[TBL] [Abstract][Full Text] [Related]
9. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.
Dieudé P; Guedj M; Wipff J; Ruiz B; Riemekasten G; Matucci-Cerinic M; Melchers I; Hachulla E; Airo P; Diot E; Hunzelmann N; Cabane J; Mouthon L; Cracowski JL; Riccieri V; Distler J; Meyer O; Kahan A; Boileau C; Allanore Y
Ann Rheum Dis; 2010 Nov; 69(11):1958-64. PubMed ID: 20511617
[TBL] [Abstract][Full Text] [Related]
10. A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis.
Koumakis E; Bouaziz M; Dieudé P; Ruiz B; Riemekasten G; Airo P; Müller-Nurasyid M; Cusi D; Matucci-Cerinic M; Melchers I; Salvi E; Strauch K; Peters A; Cuomo G; Hachulla E; Diot E; Hunzelmann N; Caramaschi P; Riccieri V; Distler JH; Tarner I; Avouac J; Letenneur L; Amouyel P; Lambert JC; Chiocchia G; Boileau C; Allanore Y
Arthritis Rheum; 2013 Dec; 65(12):3202-8. PubMed ID: 23983073
[TBL] [Abstract][Full Text] [Related]
11. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.
Dieudé P; Wipff J; Guedj M; Ruiz B; Melchers I; Hachulla E; Riemekasten G; Diot E; Hunzelmann N; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Distler J; Amoura Z; Tarner I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Nov; 60(11):3447-54. PubMed ID: 19877059
[TBL] [Abstract][Full Text] [Related]
12. PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population.
Terao C; Ohmura K; Kawaguchi Y; Nishimoto T; Kawasaki A; Takehara K; Furukawa H; Kochi Y; Ota Y; Ikari K; Sato S; Tohma S; Yamada R; Yamamoto K; Kubo M; Yamanaka H; Kuwana M; Tsuchiya N; Matsuda F; Mimori T
Arthritis Rheum; 2013 Feb; 65(2):472-80. PubMed ID: 23124809
[TBL] [Abstract][Full Text] [Related]
13. Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.
Dieudé P; Bouaziz M; Guedj M; Riemekasten G; Airò P; Müller M; Cusi D; Matucci-Cerinic M; Melchers I; Koenig W; Salvi E; Wichmann HE; Cuomo G; Hachulla E; Diot E; Hunzelmann N; Caramaschi P; Mouthon L; Riccieri V; Distler J; Tarner I; Avouac J; Meyer O; Kahan A; Chiocchia G; Boileau C; Allanore Y
Arthritis Rheum; 2011 Dec; 63(12):3979-87. PubMed ID: 21898345
[TBL] [Abstract][Full Text] [Related]
14. Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese.
Wang J; Yi L; Guo X; Liu M; Li H; Zou H; Gu Y; Tu W; Guo G; Yang L; Lai S; He D; Zhou X
Int J Immunopathol Pharmacol; 2014; 27(4):635-8. PubMed ID: 25572744
[TBL] [Abstract][Full Text] [Related]
15. A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis.
Marangoni RG; Korman BD; Allanore Y; Dieude P; Armstrong LL; Rzhetskaya M; Hinchcliff M; Carns M; Podlusky S; Shah SJ; Ruiz B; Hachulla E; Tiev K; Cracowski JL; Varga J; Hayes MG
Arthritis Res Ther; 2015 May; 17(1):128. PubMed ID: 25986483
[TBL] [Abstract][Full Text] [Related]
16. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Avouac J; Fajardy I; Diot E; Granel B; Sibilia J; Cabane J; Mouthon L; Cracowski JL; Carpentier PH; Hachulla E; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Jan; 60(1):225-33. PubMed ID: 19116937
[TBL] [Abstract][Full Text] [Related]
17. Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up.
Martin JE; Broen JC; Carmona FD; Teruel M; Simeon CP; Vonk MC; van 't Slot R; Rodriguez-Rodriguez L; Vicente E; Fonollosa V; Ortego-Centeno N; González-Gay MA; García-Hernández FJ; de la Peña PG; Carreira P; ; Voskuyl AE; Schuerwegh AJ; van Riel PL; Kreuter A; Witte T; Riemekasten G; Airo P; Scorza R; Lunardi C; Hunzelmann N; Distler JH; Beretta L; van Laar J; Chee MM; Worthington J; Herrick A; Denton C; Tan FK; Arnett FC; Assassi S; Fonseca C; Mayes MD; Radstake TR; Koeleman BP; Martin J
Hum Mol Genet; 2012 Jun; 21(12):2825-35. PubMed ID: 22407130
[TBL] [Abstract][Full Text] [Related]
18. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
Gorlova O; Martin JE; Rueda B; Koeleman BP; Ying J; Teruel M; Diaz-Gallo LM; Broen JC; Vonk MC; Simeon CP; Alizadeh BZ; Coenen MJ; Voskuyl AE; Schuerwegh AJ; van Riel PL; Vanthuyne M; van 't Slot R; Italiaander A; Ophoff RA; Hunzelmann N; Fonollosa V; Ortego-Centeno N; González-Gay MA; García-Hernández FJ; González-Escribano MF; Airo P; van Laar J; Worthington J; Hesselstrand R; Smith V; de Keyser F; Houssiau F; Chee MM; Madhok R; Shiels PG; Westhovens R; Kreuter A; de Baere E; Witte T; Padyukov L; Nordin A; Scorza R; Lunardi C; Lie BA; Hoffmann-Vold AM; Palm O; García de la Peña P; Carreira P; ; Varga J; Hinchcliff M; Lee AT; Gourh P; Amos CI; Wigley FM; Hummers LK; Nelson JL; Riemekasten G; Herrick A; Beretta L; Fonseca C; Denton CP; Gregersen PK; Agarwal S; Assassi S; Tan FK; Arnett FC; Radstake TR; Mayes MD; Martin J
PLoS Genet; 2011 Jul; 7(7):e1002178. PubMed ID: 21779181
[TBL] [Abstract][Full Text] [Related]
20. A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis.
Koumakis E; Bouaziz M; Dieudé P; Cauvet A; Ruiz B; Airò P; Cusi D; Matucci-Cerinic M; Salvi E; Cuomo G; Hachulla E; Diot E; Caramaschi P; Riccieri V; Avouac J; Allanore Y
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):43-48. PubMed ID: 27385538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
